{"id":2667,"date":"2016-12-01T16:20:05","date_gmt":"2016-12-01T15:20:05","guid":{"rendered":"https:\/\/www.rcts.fr\/uncategorized\/etude-de-suivi-en-conditions-reelles-de-traitement-des-patients-pris-en-charge-par-deferasirox"},"modified":"2020-04-07T16:04:56","modified_gmt":"2020-04-07T14:04:56","slug":"etude-de-suivi-en-conditions-reelles-de-traitement-des-patients-pris-en-charge-par-deferasirox","status":"publish","type":"post","link":"https:\/\/www.rcts.fr\/en\/etude-de-suivi-en-conditions-reelles-de-traitement-des-patients-pris-en-charge-par-deferasirox\/","title":{"rendered":"\u00c9tude de suivi en conditions r\u00e9elles de traitement des patients pris en charge par d\u00e9f\u00e9rasirox"},"content":{"rendered":"<p>Etude postinscription men\u00e9e \u00e0 la demande de la Commission de la transparence dont l\u2019objectif \u00e9tait de d\u00e9crire en situation r\u00e9elle de traitement, l\u2019\u00e9volution de la surcharge en fer secondaire, marqueur de substitution des complications cardiaques, chez les patients trait\u00e9s au long cours par d\u00e9f\u00e9rasirox.<br \/>\n<a href=\"http:\/\/www.em-consulte.com\/article\/1097481\/etude-de-suivi-en-conditions-reelles-de-traitement\" rel=\"noopener noreferrer\" target=\"_blank\">D\u00e9cembre 2016 &#8211; revue d&#8217;\u00e9pid\u00e9miologie et de sant\u00e9 publique<\/a><br \/>\nF. Galacteros, J. Guilhot, I. Thuret, M. Hacini, O. Beyne-Rauzy, C. Badens, M.C. Simeoni, J. Neyra, <strong>A. Baleydier<\/strong>, C. Rose<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Etude postinscription men\u00e9e \u00e0 la demande de la Commission de la transparence dont l\u2019objectif \u00e9tait de d\u00e9crire en situation r\u00e9elle de traitement, l\u2019\u00e9volution de la surcharge en fer secondaire, marqueur de substitution des complications cardiaques, chez les patients trait\u00e9s au long cours par d\u00e9f\u00e9rasirox. D\u00e9cembre 2016 &#8211; revue d&#8217;\u00e9pid\u00e9miologie et de sant\u00e9 publique F. Galacteros, [&hellip;]<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false},"categories":[67],"class_list":["post-2667","post","type-post","status-publish","format-standard","hentry","category-transplantation-en"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>\u00c9tude de suivi en conditions r\u00e9elles de traitement des patients pris en charge par d\u00e9f\u00e9rasirox - RCTs<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"http:\/\/www.rcts.fr\/en\/etude-de-suivi-en-conditions-reelles-de-traitement-des-patients-pris-en-charge-par-deferasirox\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"\u00c9tude de suivi en conditions r\u00e9elles de traitement des patients pris en charge par d\u00e9f\u00e9rasirox - RCTs\" \/>\n<meta property=\"og:description\" content=\"Etude postinscription men\u00e9e \u00e0 la demande de la Commission de la transparence dont l\u2019objectif \u00e9tait de d\u00e9crire en situation r\u00e9elle de traitement, l\u2019\u00e9volution de la surcharge en fer secondaire, marqueur de substitution des complications cardiaques, chez les patients trait\u00e9s au long cours par d\u00e9f\u00e9rasirox. D\u00e9cembre 2016 &#8211; revue d&#8217;\u00e9pid\u00e9miologie et de sant\u00e9 publique F. Galacteros, [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"http:\/\/www.rcts.fr\/en\/etude-de-suivi-en-conditions-reelles-de-traitement-des-patients-pris-en-charge-par-deferasirox\/\" \/>\n<meta property=\"og:site_name\" content=\"RCTs\" \/>\n<meta property=\"article:published_time\" content=\"2016-12-01T15:20:05+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2020-04-07T14:04:56+00:00\" \/>\n<meta name=\"author\" content=\"Didier Not\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Didier Not\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"http:\\\/\\\/www.rcts.fr\\\/en\\\/etude-de-suivi-en-conditions-reelles-de-traitement-des-patients-pris-en-charge-par-deferasirox\\\/#article\",\"isPartOf\":{\"@id\":\"http:\\\/\\\/www.rcts.fr\\\/en\\\/etude-de-suivi-en-conditions-reelles-de-traitement-des-patients-pris-en-charge-par-deferasirox\\\/\"},\"author\":{\"name\":\"Didier Not\",\"@id\":\"https:\\\/\\\/www.rcts.fr\\\/#\\\/schema\\\/person\\\/19ff6b0ca72b83f30ac0a23e6ce05dc5\"},\"headline\":\"\u00c9tude de suivi en conditions r\u00e9elles de traitement des patients pris en charge par d\u00e9f\u00e9rasirox\",\"datePublished\":\"2016-12-01T15:20:05+00:00\",\"dateModified\":\"2020-04-07T14:04:56+00:00\",\"mainEntityOfPage\":{\"@id\":\"http:\\\/\\\/www.rcts.fr\\\/en\\\/etude-de-suivi-en-conditions-reelles-de-traitement-des-patients-pris-en-charge-par-deferasirox\\\/\"},\"wordCount\":101,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/www.rcts.fr\\\/#organization\"},\"articleSection\":[\"Transplantation\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"http:\\\/\\\/www.rcts.fr\\\/en\\\/etude-de-suivi-en-conditions-reelles-de-traitement-des-patients-pris-en-charge-par-deferasirox\\\/\",\"url\":\"http:\\\/\\\/www.rcts.fr\\\/en\\\/etude-de-suivi-en-conditions-reelles-de-traitement-des-patients-pris-en-charge-par-deferasirox\\\/\",\"name\":\"\u00c9tude de suivi en conditions r\u00e9elles de traitement des patients pris en charge par d\u00e9f\u00e9rasirox - RCTs\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.rcts.fr\\\/#website\"},\"datePublished\":\"2016-12-01T15:20:05+00:00\",\"dateModified\":\"2020-04-07T14:04:56+00:00\",\"breadcrumb\":{\"@id\":\"http:\\\/\\\/www.rcts.fr\\\/en\\\/etude-de-suivi-en-conditions-reelles-de-traitement-des-patients-pris-en-charge-par-deferasirox\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"http:\\\/\\\/www.rcts.fr\\\/en\\\/etude-de-suivi-en-conditions-reelles-de-traitement-des-patients-pris-en-charge-par-deferasirox\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"http:\\\/\\\/www.rcts.fr\\\/en\\\/etude-de-suivi-en-conditions-reelles-de-traitement-des-patients-pris-en-charge-par-deferasirox\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.rcts.fr\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"\u00c9tude de suivi en conditions r\u00e9elles de traitement des patients pris en charge par d\u00e9f\u00e9rasirox\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.rcts.fr\\\/#website\",\"url\":\"https:\\\/\\\/www.rcts.fr\\\/\",\"name\":\"RCTs\",\"description\":\"Description\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.rcts.fr\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.rcts.fr\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.rcts.fr\\\/#organization\",\"name\":\"RCTs\",\"url\":\"https:\\\/\\\/www.rcts.fr\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.rcts.fr\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/www.rcts.fr\\\/wp-content\\\/uploads\\\/logo-blue.svg\",\"contentUrl\":\"https:\\\/\\\/www.rcts.fr\\\/wp-content\\\/uploads\\\/logo-blue.svg\",\"width\":163,\"height\":47,\"caption\":\"RCTs\"},\"image\":{\"@id\":\"https:\\\/\\\/www.rcts.fr\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.rcts.fr\\\/#\\\/schema\\\/person\\\/19ff6b0ca72b83f30ac0a23e6ce05dc5\",\"name\":\"Didier Not\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/384084503863c2fae1497cd4aff02d7d7ec7ec0d357eb358655b55a5dd586850?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/384084503863c2fae1497cd4aff02d7d7ec7ec0d357eb358655b55a5dd586850?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/384084503863c2fae1497cd4aff02d7d7ec7ec0d357eb358655b55a5dd586850?s=96&d=mm&r=g\",\"caption\":\"Didier Not\"},\"url\":\"https:\\\/\\\/www.rcts.fr\\\/en\\\/author\\\/dnorcts-fr\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"\u00c9tude de suivi en conditions r\u00e9elles de traitement des patients pris en charge par d\u00e9f\u00e9rasirox - RCTs","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"http:\/\/www.rcts.fr\/en\/etude-de-suivi-en-conditions-reelles-de-traitement-des-patients-pris-en-charge-par-deferasirox\/","og_locale":"en_US","og_type":"article","og_title":"\u00c9tude de suivi en conditions r\u00e9elles de traitement des patients pris en charge par d\u00e9f\u00e9rasirox - RCTs","og_description":"Etude postinscription men\u00e9e \u00e0 la demande de la Commission de la transparence dont l\u2019objectif \u00e9tait de d\u00e9crire en situation r\u00e9elle de traitement, l\u2019\u00e9volution de la surcharge en fer secondaire, marqueur de substitution des complications cardiaques, chez les patients trait\u00e9s au long cours par d\u00e9f\u00e9rasirox. D\u00e9cembre 2016 &#8211; revue d&#8217;\u00e9pid\u00e9miologie et de sant\u00e9 publique F. Galacteros, [&hellip;]","og_url":"http:\/\/www.rcts.fr\/en\/etude-de-suivi-en-conditions-reelles-de-traitement-des-patients-pris-en-charge-par-deferasirox\/","og_site_name":"RCTs","article_published_time":"2016-12-01T15:20:05+00:00","article_modified_time":"2020-04-07T14:04:56+00:00","author":"Didier Not","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Didier Not"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"http:\/\/www.rcts.fr\/en\/etude-de-suivi-en-conditions-reelles-de-traitement-des-patients-pris-en-charge-par-deferasirox\/#article","isPartOf":{"@id":"http:\/\/www.rcts.fr\/en\/etude-de-suivi-en-conditions-reelles-de-traitement-des-patients-pris-en-charge-par-deferasirox\/"},"author":{"name":"Didier Not","@id":"https:\/\/www.rcts.fr\/#\/schema\/person\/19ff6b0ca72b83f30ac0a23e6ce05dc5"},"headline":"\u00c9tude de suivi en conditions r\u00e9elles de traitement des patients pris en charge par d\u00e9f\u00e9rasirox","datePublished":"2016-12-01T15:20:05+00:00","dateModified":"2020-04-07T14:04:56+00:00","mainEntityOfPage":{"@id":"http:\/\/www.rcts.fr\/en\/etude-de-suivi-en-conditions-reelles-de-traitement-des-patients-pris-en-charge-par-deferasirox\/"},"wordCount":101,"commentCount":0,"publisher":{"@id":"https:\/\/www.rcts.fr\/#organization"},"articleSection":["Transplantation"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"http:\/\/www.rcts.fr\/en\/etude-de-suivi-en-conditions-reelles-de-traitement-des-patients-pris-en-charge-par-deferasirox\/","url":"http:\/\/www.rcts.fr\/en\/etude-de-suivi-en-conditions-reelles-de-traitement-des-patients-pris-en-charge-par-deferasirox\/","name":"\u00c9tude de suivi en conditions r\u00e9elles de traitement des patients pris en charge par d\u00e9f\u00e9rasirox - RCTs","isPartOf":{"@id":"https:\/\/www.rcts.fr\/#website"},"datePublished":"2016-12-01T15:20:05+00:00","dateModified":"2020-04-07T14:04:56+00:00","breadcrumb":{"@id":"http:\/\/www.rcts.fr\/en\/etude-de-suivi-en-conditions-reelles-de-traitement-des-patients-pris-en-charge-par-deferasirox\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["http:\/\/www.rcts.fr\/en\/etude-de-suivi-en-conditions-reelles-de-traitement-des-patients-pris-en-charge-par-deferasirox\/"]}]},{"@type":"BreadcrumbList","@id":"http:\/\/www.rcts.fr\/en\/etude-de-suivi-en-conditions-reelles-de-traitement-des-patients-pris-en-charge-par-deferasirox\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.rcts.fr\/en\/"},{"@type":"ListItem","position":2,"name":"\u00c9tude de suivi en conditions r\u00e9elles de traitement des patients pris en charge par d\u00e9f\u00e9rasirox"}]},{"@type":"WebSite","@id":"https:\/\/www.rcts.fr\/#website","url":"https:\/\/www.rcts.fr\/","name":"RCTs","description":"Description","publisher":{"@id":"https:\/\/www.rcts.fr\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.rcts.fr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/www.rcts.fr\/#organization","name":"RCTs","url":"https:\/\/www.rcts.fr\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.rcts.fr\/#\/schema\/logo\/image\/","url":"https:\/\/www.rcts.fr\/wp-content\/uploads\/logo-blue.svg","contentUrl":"https:\/\/www.rcts.fr\/wp-content\/uploads\/logo-blue.svg","width":163,"height":47,"caption":"RCTs"},"image":{"@id":"https:\/\/www.rcts.fr\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/www.rcts.fr\/#\/schema\/person\/19ff6b0ca72b83f30ac0a23e6ce05dc5","name":"Didier Not","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/384084503863c2fae1497cd4aff02d7d7ec7ec0d357eb358655b55a5dd586850?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/384084503863c2fae1497cd4aff02d7d7ec7ec0d357eb358655b55a5dd586850?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/384084503863c2fae1497cd4aff02d7d7ec7ec0d357eb358655b55a5dd586850?s=96&d=mm&r=g","caption":"Didier Not"},"url":"https:\/\/www.rcts.fr\/en\/author\/dnorcts-fr\/"}]}},"_links":{"self":[{"href":"https:\/\/www.rcts.fr\/en\/wp-json\/wp\/v2\/posts\/2667","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.rcts.fr\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.rcts.fr\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.rcts.fr\/en\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.rcts.fr\/en\/wp-json\/wp\/v2\/comments?post=2667"}],"version-history":[{"count":1,"href":"https:\/\/www.rcts.fr\/en\/wp-json\/wp\/v2\/posts\/2667\/revisions"}],"predecessor-version":[{"id":2668,"href":"https:\/\/www.rcts.fr\/en\/wp-json\/wp\/v2\/posts\/2667\/revisions\/2668"}],"wp:attachment":[{"href":"https:\/\/www.rcts.fr\/en\/wp-json\/wp\/v2\/media?parent=2667"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.rcts.fr\/en\/wp-json\/wp\/v2\/categories?post=2667"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}